Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Johnson & Johnson Subsidiary Files for Bankruptcy for the Third Time, Aiming to Shed $100 Billion in Debt, Thousands of Cancer Patients Left Without Recourse!

Johnson & Johnson Subsidiary Files for Bankruptcy for the Third Time, Aiming to Shed $100 Billion in Debt, Thousands of Cancer Patients Left Without Recourse!

ECHEMI 2024-09-29

A unit of Johnson & Johnson filed for bankruptcy Wednesday for the third time, Reuters reported, aiming to advance a $10 billion settlement to end tens of thousands of lawsuits alleging the company's baby powder and other talc products may cause cancer.

More than 62,000 plaintiffs have claimed that Johnson's baby powder and other talc products are contaminated and that they cause ovarian cancer and other types of cancer. In response to the lawsuits, J&J's subsidiary, Red River Talc, has filed for bankruptcy protection in federal bankruptcy court in Houston.

Erik Haas, Johnson & Johnson's vice president of global litigation, said the settlement was "fair and reasonable for all parties," noting that 83 percent of claimants have now supported it.

However, the proposed settlement has sparked controversy among a group of lawyers representing cancer victims. Some opponents said they would move quickly to ask the court to dismiss J&J's bankruptcy filing or have it moved to New Jersey. New Jersey courts have twice rejected J&J's attempts to end litigation through a so-called "Texas two-step" bankruptcy strategy.

Andy Birchfield, a lawyer who opposed the deal, pointed out that Johnson & Johnson is trying to use the bankruptcy system to reduce its liability to tens of thousands of cancer patients.

The report further explained that the "two-step" strategy used by J&J involved transferring debt to a newly formed subsidiary, which subsequently declared bankruptcy. This is a court-supervised asset and debt restructuring process designed to force all plaintiffs to accept a settlement.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.